2m 2m 2m 2m 2m 2m 2m
Vertex Pharma (VRTX)
NASDAQ
$476.77-$0.33 (-0.07%)
Price as of Jul 31, 2026 7:59 PM EDT- $121.1BMarket Cap
- 3.24%1-Year Change
- BiotechnologyIndustry
Vertex Pharma (VRTX)
$476.77-$0.33 (-0.07%)
VRTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $477.10 | ||
Change | -$4.60 (-0.95%) | ||
Open | $480.67 | ||
High | $480.67 | ||
Low | $469.87 | ||
Previous Close | $481.70 | ||
Volume | 957,710 | ||
30-Day Average Volume | 1,471,552 | ||
1-Week Change | -0.05% | ||
1-Month Change | -3.95% | ||
1-Year Change | 3.24% | ||
3-Year Change | 35.41% | ||
5-Year Change | 136.68% | ||
Fundamentals | |||
Shares Outstanding | 253.8M | ||
Total Assets | $26.5B | ||
Market Cap | $121.1B | ||
Enterprise Value | $115.6B | ||
Period: QTR TTM FY | |||
Revenue | $3.0B | ||
Net Income | $1.0B | ||
Free Cash Flow | $1.3B | ||
EBIT | $1.3B | ||
EBITDA | $1.3B | ||
Net Working Capital | $7.8B | ||
EPS | $4.02 | ||
Enterprise Value/EBITDA | 88 | ||
Enterprise Value/Revenue | 39 | ||
P/B | 6 | ||
P/E | 119 | ||
PEG | -9 | ||
Price/Free Cash Flow | 94 | ||
Price/Operating Cash Flow | 85 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue